Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Combining physical rehab with PRP injections helps athletes recover from supraspinatus tendonitis.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

Caloric stress and differentiation increase IRES translation, affecting stem cell function and potential therapies.

Better-designed, long-term studies are needed to optimize treatment for trichotillomania and trichophagia.

Mitochondrial features can predict colorectal cancer outcomes and improve immunotherapy.

Ritlecitinib is an effective new treatment for Alopecia Areata.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

A new mutation in the FLCN gene linked to Birt-Hogg-Dube syndrome was found, suggesting people with certain lung collapse should be tested for this mutation and screened for kidney and colon cancer.

The consensus provided guidelines for treating the Female Athlete Triad and a system to decide when athletes can return to sports.

Trichotillomania is a chronic hair-pulling disorder, more common in females, treated with therapy and sometimes medication.

A woman with a skin disorder was found to have hepatitis C, which may be linked, and was safely treated with methotrexate.

Standardized de-facing protocols can prevent identification from anonymized MRI images, enhancing privacy protection.

Hair from breast cancer patients shows changes in structure and composition, and a test using these changes detected cancer but also falsely identified some healthy samples as cancerous.

A multidisciplinary approach effectively improves trichotillomania without side effects.

You might not need to stop cancer treatment if you get a rare skin reaction from EGFR inhibitors, as skin treatments can help manage it.

A woman with HIV had a severe skin condition that improved with antiretroviral therapy.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Early diagnosis and treatment are crucial to prevent permanent hair loss from scalp trauma.

TTD symptoms vary widely, requiring thorough evaluations.

Dermatology trainees lack standardized guidelines and education for treating testosterone-induced skin conditions in transmasculine individuals.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Combining PRS with TAFR is promising for treating complex fistulas, with most patients achieving long-term healing.

Testosterone with finasteride improved muscle and bone health in men with spinal cord injury.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Testosterone treatment in transgender teens can worsen acne, requiring careful treatment due to mental health and medication side effects.

Single-dose parenteral iron is safe and effective for children with inflammatory bowel disease and iron-deficiency anemia.